This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (9) Citing Articles via Google Scholar Google Scholar Articles by Giannitsis, E. Articles by Katus, H. A. Search for Related Content PubMed Articles by Giannitsis, E. Articles by Katus, H. A.

CLINICAL RESEARCH: CARDIAC IMAGING

Cardiac Magnetic Resonance Imaging Study for Quantification of Infarct Size Comparing Directly Serial Versus Single Time-Point Measurements of Cardiac Troponin T

Evangelos Giannitsis, MD^_*,1,4, Henning Steen, MD^_*,4, Kerstin Kurz, MD^_*, Boris Ivandic, MD^_*, Anke C. Simon, MD^_*, Simon Futterer, MD^_*, Christian Schild, MD^_*, Peter Isfort, MD^_*, Allan S. Jaffe, MD, FACC^,3,_* and Hugo A. Katus, MD, FACC^_*,2

^_* Abteilung Innere Medizin III, Medizinische Klinik, Universitätsklinikum Heidelberg, Heidelberg, Germany
Mayo Clinic and Mayo Medical School, Rochester, Minnesota.

Manuscript received March 23, 2007; revised manuscript received August 10, 2007, accepted September 7, 2007.

^_* Reprint requests and correspondence: Dr. Allan S. Jaffe, Mayo Clinic and Mayo Medical School, CV Division, Gonda 5, 200 First Street SW, Rochester, Minnesota 55905. (Email: Jaffe.Allan{at}mayo.edu).

Objectives: We compared single-point cardiac troponin T (cTnT) measurements with parameters from serial sampling during 96 h after acute myocardial infarction with magnetic resonance imaging measured infarct mass.

Background: Contrast-enhanced magnetic resonance imaging (CE-MRI) allows exact quantification of myocardial infarct size. Clinically, measurement of cardiac biomarkers is a more convenient alternative.

Methods: The CE-MRI infarct mass was determined 4 days after primary percutaneous coronary intervention in 31 ST-segment elevation myocardial infarction (STEMI) and 30 non–ST-segment elevation myocardial infarction (NSTEMI) patients. All single-point, peak, and integrated area under the curve (AUC) cTnT values were plotted against CE-MRI infarct mass.

Results: All single-point and serial cTnT values were significantly higher in STEMI than in NSTEMI (p < 0.01) patients. Except for the admission values, all single-point values on any of the first 4 days, peak cTnT and AUC cTnT were found to correlate comparably well with infarct mass. Among single-point measurements, cTnT on day 4 (cTnTD4) showed highest correlation and performed as well as peak cTnT or AUC cTnT (r = 0.66 vs. r = 0.65 vs. r = 0.69). Receiver-operator characteristic analysis demonstrated that cTnTD4 >0.84 µg/l predicted infarct mass above median as well as peak cTnT >1.57 µg/l or AUC cTnT (receiver-operator characteristic for AUC: 0.839 vs. 0.866 vs. 0.893). However, estimation of infarct mass with cTnTD4, peak cTnT, and AUC cTnT was worse in patients with NSTEMI (r = 0.36, r = 0.5, r = 0.36) than in STEMI (r = 0.75 vs. r = 0.65 vs. r = 0.76).

Conclusions: All single-point cTnTs, except on admission, give a good estimation of infarct size and perform as well as peak cTnT or AUC cTnT. Infarct estimation by single-point measurements, particularly cTnTD4, may gain clinical acceptance because the measurement is easy and inexpensive.

Abbreviations and Acronyms   AMI = acute myocardial infarction   AUC = area under the curve   CE-MRI = contrast-enhanced magnetic resonance imaging   CI = confidence interval   CK-MB = creatine kinase-MB fraction   CMR = cardiovascular magnetic resonance   cTnI/T = cardiac troponin I or T   MR = magnetic resonance   MRI = magnetic resonance imaging   NSTEMI = non–ST-segment elevation myocardial infarction   PCI = percutaneous coronary intervention   ROC = receiver-operator characteristic   SPECT = single-photon emission computed tomography   STEMI = ST-segment elevation myocardial infarction

This article has been cited by other articles:

				A. N. DeMaria, O. Ben-Yehuda, J. J. Bax, G. K. Feld, B. H. Greenberg, W. Y.W. Lew, J. A.C. Lima, A. S. Maisel, S. M. Narayan, D. J. Sahn, et al. Highlights of the Year in JACC 2008. J. Am. Coll. Cardiol., January 27, 2009; 53(4): 373 - 398. [Full Text] [PDF]

				A. K. Saenger and A. S. Jaffe Requiem for a Heavyweight: The Demise of Creatine Kinase-MB Circulation, November 18, 2008; 118(21): 2200 - 2206. [Full Text] [PDF]

				A. S. Jaffe Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers Clin. Chem., September 1, 2008; 54(9): 1432 - 1442. [Abstract] [Full Text] [PDF]

				F. Leuschner, J. Li, S. Goser, L. Reinhardt, R. Ottl, P. Bride, J. Zehelein, G. Pfitzer, A. Remppis, E. Giannitsis, et al. Absence of auto-antibodies against cardiac troponin I predicts improvement of left ventricular function after acute myocardial infarction Eur. Heart J., August 2, 2008; 29(16): 1949 - 1955. [Abstract] [Full Text] [PDF]

				S. Chia, F. Senatore, O. C. Raffel, H. Lee, F. J. Th. Wackers, and I.-K. Jang Utility of Cardiac Biomarkers in Predicting Infarct Size, Left Ventricular Function, and Clinical Outcome After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction J. Am. Coll. Cardiol. Intv., August 1, 2008; 1(4): 415 - 423. [Abstract] [Full Text] [PDF]

				V. C. Vasile, L. Babuin, E. Giannitsis, H. A. Katus, and A. S. Jaffe Relationship of MRI-Determined Infarct Size and cTnI Measurements in Patients with ST-Elevation Myocardial Infarction Clin. Chem., March 1, 2008; 54(3): 617 - 619. [Full Text] [PDF]